Compare Corticosteroid

15 products »

close Created with Sketch.

Dextenza

Ocular Therapeutix, Inc.

Dextenza (dexamethazone insert) 0.4mg is a corticosteroid intracanalicular insert placed through the punctum into the canaliculus and is designed to deliver dexamethasone to the ocular surface for up to 30 days without preservatives.  Following treatment, Dextenza is intended to resorb and exit the nasolacrimal system without the need for removal.

Dextenza has completed Phase 3 evaluation for the treatment of ocular pain and inflammation following ophthalmic surgery. DEXTENZA is also being studied for allergic conjunctivitis.

At-a-Glance
  • Dosage: hydrogel insert designed to release a tapered dose of dexamethasone

Details

FDA

Under investigation

CE Mark

No

Active Ingredients

Dexamethasone

Application

Intracanalicular insertion

Status

Prescription

Strength

0.4 mg

Company Information

Contact the company for additional information, availability, or pricing:

Ocular Therapeutix, Inc.

ocutx.com

15 Crosby Drive

Bedford, MA 01730